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Introduction
There are tens of thousands of natural and 
synthetic chemical substances to which 
humans and wildlife are exposed (Dionisio 
et al. 2015; Egeghy et al. 2012; Judson et al. 
2009). A subset of these compounds may 
disrupt normal functioning of the endocrine 
system and cause health hazards to both 
humans and ecological species (Birnbaum 
and Fenton 2003; Diamanti-Kandarakis 
et al. 2009; Mahoney and Padmanabhan 
2010; UNEP and WHO 2013). Endocrine-
disrupting chemicals (EDCs) can mimic or 
interfere with natural hormones and alter 
their mechanisms of action at the receptor 
level, as well as interfere with the synthesis, 
transport, and metabolism of endogenous 
hormones (Diamanti-Kandarakis et al. 2009). 
Exposure to EDCs can lead to adverse health 
effects involving developmental, neurological, 
reproductive, metabolic, cardiovascular, and 
immune systems in humans and wildlife 
(Colborn et al. 1993; Davis et al. 1993; 
Diamanti-Kandarakis et al. 2009).
The estrogen receptor (ER) is one of the 
most extensively studied targets related to the 
effects of EDCs (Mueller and Korach 2001; 
Shanle and Xu 2011). This concern about 
estrogen-like activity of man-made chemicals 
is because of their potential for negatively 
affecting reproductive function (Hileman 
1994; Kavlock et al. 1996). The emergence of 
concerns about EDCs has resulted in regula-
tions requiring assessment of chemicals for 
estrogenic activity [Adler et al. 2011; U.S. 
Environmental Protection Agency (EPA) 
1996; U.S. Food and Drug Administration 
(FDA) 1996]. There are numerous in vitro 
and in vivo protocols to identify potential 
endocrine pathway-mediated effects of chem-
icals, including interactions with hormone 
receptors (Jacobs et al. 2008; Rotroff et al. 
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Background: Humans are exposed to thousands of man-made chemicals in the environment. 
Some chemicals mimic natural endocrine hormones and, thus, have the potential to be endocrine 
disruptors. Most of these chemicals have never been tested for their ability to interact with the 
estrogen receptor (ER). Risk assessors need tools to prioritize chemicals for evaluation in costly 
in vivo tests, for instance, within the U.S. EPA Endocrine Disruptor Screening Program.
oBjectives: We describe a large-scale modeling project called CERAPP (Collaborative Estrogen 
Receptor Activity Prediction Project) and demonstrate the efficacy of using predictive computa-
tional models trained on high-throughput screening data to evaluate thousands of chemicals for 
ER-related activity and prioritize them for further testing.
Methods: CERAPP combined multiple models developed in collaboration with 17 groups in the 
United States and Europe to predict ER activity of a common set of 32,464 chemical structures. 
Quantitative structure–activity relationship models and docking approaches were employed, mostly 
using a common training set of 1,677 chemical structures provided by the U.S. EPA, to build a total of 
40 categorical and 8 continuous models for binding, agonist, and antagonist ER activity. All predictions 
were evaluated on a set of 7,522 chemicals curated from the literature. To overcome the limitations of 
single models, a consensus was built by weighting models on scores based on their evaluated accuracies.
results: Individual model scores ranged from 0.69 to 0.85, showing high prediction reliabilities. 
Out of the 32,464 chemicals, the consensus model predicted 4,001 chemicals (12.3%) as high 
priority actives and 6,742 potential actives (20.8%) to be considered for further testing.
conclusion: This project demonstrated the possibility to screen large libraries of chemicals using a 
consensus of different in silico approaches. This concept will be applied in future projects related to 
other end points.
citation: Mansouri K, Abdelaziz A, Rybacka A, Roncaglioni A, Tropsha A, Varnek A, Zakharov A, 
Worth A, Richard AM, Grulke CM, Trisciuzzi D, Fourches D, Horvath D, Benfenati E, 
Muratov E, Wedebye EB, Grisoni F, Mangiatordi GF, Incisivo GM, Hong H, Ng HW, Tetko IV, 
Balabin I, Kancherla J, Shen J, Burton J, Nicklaus M, Cassotti M, Nikolov NG, Nicolotti O, 
Andersson PL, Zang Q, Politi R, Beger RD, Todeschini R, Huang R, Farag S, Rosenberg SA, 
Slavov S, Hu X, Judson RS. 2016. CERAPP: Collaborative Estrogen Receptor Activity Prediction 
Project. Environ Health Perspect 124:1023–1033; http://dx.doi.org/10.1289/ehp.1510267
Mansouri et al.
1024 volume 124 | number 7 | July 2016 • Environmental Health Perspectives
2013; Shanle and Xu 2011; Sung et al. 2012). 
However, experimental testing of chemicals is 
expensive and time-consuming and currently 
impractical for application to the vast number 
of synthetic chemicals in use. Consequently, 
toxicological data and especially estrogenic 
activity data are available only for a limited 
number of compounds (Cohen Hubal et al. 
2010; Egeghy et al. 2012; Judson et al. 2009).
The use of in silico approaches, such as 
quantitative structure–activity relationships 
(QSARs), is an alternative to bridge the lack 
of knowledge about chemicals when little 
or no experimental data are available. These 
structure-based methods are particularly 
appealing for their ability to predict toxi-
cologically relevant end points quickly and 
at low cost (Muster et al. 2008; Vedani and 
Smiesko 2009). QSARs have been promoted 
and their use recognized since the pioneering 
work of Hansch in the 1960s (Fujita et al. 
1964; Hansch et al. 1962; Hansch and 
Deutsch 1966). The conceptual basis of 
QSARs is that chemicals with similar struc-
tures are hypothesized to exhibit similar 
behavior in living organisms. Thus, it should 
be possible to predict biological activity of 
new chemicals based on published experi-
mental data. Several guidance documents to 
develop these modeling techniques are avail-
able in the literature (Dearden et al. 2009; 
Worth et al. 2005).
Recently, in vitro high-throughput 
screening (HTS) assays have emerged and 
become a viable tool for large-scale chemical 
testing (Judson et al. 2011; Kavlock and Dix 
2010; Wetmore et al. 2012). HTS generates 
substantial amounts of data that can be used as 
a knowledge base to correlate chemical struc-
tures to their biological activities. Thus, QSARs 
can identify key structural characteristics in 
active chemicals and can use them to virtually 
screen large chemical libraries. Although there is 
concern about the overall accuracy of a QSAR 
model to predict the true activity of a particular 
chemical, accuracy can be high enough to use 
the results for prioritizing chemicals that are 
worth subjecting to experimental testing.
With the increasing number of new 
substances submitted to the U.S. EPA and the 
European Chemicals Agency for registration 
(~ 1,500 chemicals every year), there is a need 
to prioritize chemicals to speed up the process 
and lower the overall costs of testing (U.S. 
EPA 2015). The Toxicology Testing in the 
21st Century (Tox21) collaboration and the 
U.S. EPA’s Toxicity ForeCaster (ToxCast™)
projects are screening thousands of chemicals 
in HTS in vitro assays for a broad range of 
targets (Dix et al. 2007; Judson et al. 2010; 
Martin et al. 2010). Relevant to this paper, 
these two projects have in common ~ 1,800 
chemicals tested in a battery of 18 ER-related 
assays (Huang et al. 2014; Judson et al. 2015).
This paper describes the results of the 
Collaborative Estrogen Receptor Activity 
Prediction Project (CERAPP), which was 
organized by the National Center for 
Computational Toxicology at the U.S. EPA. 
The aim of the project was to use ToxCast™/
Tox21 ER HTS assay data to develop and 
optimize predictive computational models, and 
to use their predictions to prioritize a large 
chemical universe of 32,464 unique chemical 
structures for further testing. Seventeen 
research groups from the United States and 
Europe participated in this project. These 
groups submitted 40 categorical models and 8 
continuous models using different QSAR and 
structure-based approaches. Most of the newly 
developed models used a training set consisting 
of 1,677 chemicals, each assigned a potency 
score quantifying their ER agonist, antago-
nist, and binding activities, obtained from a 
computational network model that integrates 
data from 18 diverse ER HTS assays (Judson 
et al. 2015). All models were evaluated and 
weighted based on their prediction accuracy 
scores (including sensitivity and specificity) 
using ToxCast™/Tox21 HTS data, as well as 
an evaluation data set collected from different 
literature sources. To overcome the limita-
tions of single models, all predictions were 
combined into a consensus model that classi-
fied the chemicals into active/inactive binders, 
agonists, and antagonists and provided esti-
mates of their potency level relative to known 
reference chemicals.
Materials and Methods
Participants and Project Planning
The 17 international research groups that 
participated in this project are listed in alpha-
betic order in Table S1. The goals of the 
project, outlined in Table S2, were achieved 
in multiple steps, including chemical struc-
ture curation, experimental data preparation 
from the literature, modeling and predic-
tion, model evaluation, consensus strategy 
development, and consensus modeling. Each 
step was assigned to a subgroup of partici-
pants according to their interests and areas 
of expertise.
Data Sets
Provided training set. The data that were 
suggested to be used by the participants as 
a training set to develop and optimize 
their models was derived from ToxCast™ 
and Tox21 programs (Dix et al. 2007; 
Huang et al. 2014; Judson et al. 2010). 
Concentration-response data from a collec-
tion of 18 in vitro HTS assays exploring 
multiple sites in the mammalian ER pathway 
were generated for 1,812 chemicals (Judson 
et al. 2015; U.S. EPA 2014c). This chemical 
library included 45 reference ER agonists and 
antagonists (including negatives), as well as 
a wide array of commercial chemicals with 
known estrogen-like activity (Judson et al. 
2015). A mathematical model was developed 
to integrate the in vitro data and calculate an 
area under the curve (AUC) score, ranging 
from 0 to 1, which is roughly proportional 
to the consensus AC50 value across the active 
assays (Judson et al. 2015). A given chemical 
was considered active if its agonist or antago-
nist score was higher than 0.01. In order to 
reduce the number of potential false positives 
this threshold can be increased to 0.1.
Prediction set. We identified > 50,000 
chemicals [at the level of Chemical Abstracts 
Service Registry Number (CASRN)] for use in 
this project as a virtual screening library to be 
prioritized for further testing and regulatory 
purposes. This set was intended to include a 
large fraction of all man-made chemicals to 
which humans may be exposed. These chemi-
cals were collected from different sources 
with significant overlap and cover a variety of 
classes, including consumer products, food 
additives, and human and veterinary drugs. 
The following list includes the sources used in 
this project:
• Chemicals with documented use, and there-
fore, with exposure potential (~ 43,000). 
Available in the U.S. EPA chemical product 
categories database (CPCat), which is part of 
the Aggregated Computational Toxicology 
Resource (ACToR) system (Dionisio et al. 
2015; Judson et al. 2008, 2012; U.S. 
EPA 2014a).
• The Distributed Structure-Searchable 
Toxicity (DSSTox) (U.S. EPA 2014b). A 
list of ~ 15,000 curated chemical structures 
from multiple inventories of environmental 
interest. In particular, structures for all of the 
ToxCast™ and Tox21 chemicals are included.
• The Canadian Domestic Substances list 
(DSL) (Environment Canada 2012). A 
compiled list of all substances thought to 
be in commercial use in Canada (~ 24,000 
chemicals). Thus, it includes chemicals with 
potential human or ecological exposure.
• The Endocrine Disruption Screening 
Program (EDSP) universe of ~ 10,000 
chemicals. The U.S. EPA’s EDSP is required 
to test certain chemicals for their potential 
for endocrine disruption (U.S. EPA 2014d).
• A list of ~ 15,000 chemicals used as 
training and test sets for the different 
models implemented in the U.S. EPA’s 
Estimation Program Interface (EPI Suite™) 
to predict physico-chemical properties (U.S. 
EPA 2014e).
This  virtual  chemical  l ibrary has 
undergone stringent chemical structure 
processing and normalization for use in 
the QSAR modeling study (see “Chemical 
Structure Curation”) and made available 
for download on ToxCast™ Data web site 
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under CERAPP data (https://www3.epa.
gov/research/COMPTOX/CERAPP_files.
html, PredictionSet.zip) (U.S. EPA 2016), is 
intended to be employed for a large number of 
other QSAR modeling projects, not just those 
focused on endocrine-related targets.
Experimental evaluation set. A large 
volume of estrogen-related experimental data 
has accumulated in the literature over the past 
two decades. The information on the estrogenic 
activity of chemicals was mined and curated 
to serve as a validation set for predictions of 
the different models. For this purpose, in vitro 
experimental data were collected from different 
overlapping sources, including the U.S. EPA’s 
HTS assays, online databases, and other data 
sets used by  participants to train models:
• HTS data from Tox21 project consisting of 
~ 8,000 chemicals evaluated in four assays 
(Attene-Ramos et al. 2013; Collins et al. 
2008; Huang et al. 2014; Shukla et al. 2010; 
Tice et al. 2013), extending beyond the 
1,677 used in the training set.
• The U.S. FDA Estrogenic Activity Database 
(EADB), which consists of literature derived 
ER data for ~ 8,000 chemicals (Shen 
et al. 2013).
• Estrogenic data for ~ 2,000 chemicals from 
the METI (Ministry of Economy, Trade and 
Industry, Japan) database (METI 2002).
• Estrogenic data for ~ 2,000 chemicals from 
ChEMBL database (Gaulton et al. 2012).
The full data set consisted of > 60,000 
entries, including binding, agonist, and 
antagonist information for ~ 15,000 unique 
chemical structures. For the purpose of this 
project, this data set was cleaned and made 
more consistent by removing in vivo data, 
cytotoxicity information, and all ambiguous 
entries (missing values, undefined/nonstandard 
end points, and unclear units). Only 7,547 
chemical structures from the experimental eval-
uation set that overlapped with the CERAPP 
prediction set, for a total of 44,641 entries, 
were kept and made available for download 
on the U.S. EPA ToxCast™ Data web site 
(https://www3.epa.gov/research/COMPTOX/
CERAPP_files.html, EvaluationSet.zip) (U.S. 
EPA 2016). The non-CERAPP chemicals 
were excluded from the evaluation set (see 
“Chemical Structure Curation” section). 
Then, all data entries were categorized into 
three assay classes: (a) binding, (b) reporter 
gene/transactivation, or (c) cell proliferation. 
The training set end point to model is the ER 
model AUC that parallels the corresponding 
individual assay AC50 values, and therefore all 
units for activities in the experimental data set 
were converted to μM to have approximately 
equivalent  concentration– response values 
for the evaluation set. Chemicals with cell 
proliferation assays were considered as actives 
if they exceeded an arbitrary threshold of 
125% proliferation. For entries where testing 
concentrations were reported in the assay name 
field, those values were converted to μM and 
considered as the AC50 value if the compound 
was reported as active. All inactive compounds 
were arbitrarily assigned an AC50 value of 1 M.
Chemical Structure Curation
Chemical structures collected from different 
public sources contained many duplicates, 
and inconsistencies in the molecular struc-
tures. Hence, a structure curation process was 
carried out to derive a unique set of QSAR-
ready structures. All participating groups 
then used this consistent set of structures for 
both training and prediction steps. It should 
be noted that each group likely employed 
different descriptor calculation software, 
which could effectively alter structures in some 
cases. Several different curation approaches 
were combined into a unique procedure 
used for this project (Fourches et al. 2010; 
Wedebye et al. 2013). The free and open-
source data-mining environment KNIME 
(Konstanz Information Miner) was selected 
to design a curation workflow to process all 
structures and provide consistent training and 
prediction sets (Berthold et al. 2007). The 
workflow performed a series of curation steps:
1) The original files containing structures in 
different formats were parsed, checked 
for valences, and for the integrity of the 
required structural information to render 
the molecules. Invalid entries were 
corrected by retrieving a new structure 
from online databases using web services 
[PubChem (NIH 2015), ChemSpider 
(Royal Society of Chemistry 2015)] or 
removed if ambiguous.
2) The first filter was applied to check for 
the presence of carbon atoms and remove 
inorganic compounds.
3) The structures were desalted, and inor-
ganic counterions were removed.
4) The second filter, based on molecular 
weight, was applied and chemicals 
exceeding a threshold of 1,000 g/mol were 
removed to speed up molecular descriptor 
calculations and model calibration.
5) Valid QSAR modeling practice requires 
all chemicals to be structurally consis-
tent by converting tautomers to unique 
representations. Thus, a series of trans-
formations was applied on the structures 
to standardize nitro and azide mesomers, 
keto-enol tautomers, enamine-imine 
tautomers, ynol-ketene, and other conver-
sions (ChemAxon 2014; Reusch 2013; 
Sitzmann et al. 2010).
6) These transformations were followed 
by neutralizing the charged structures, 
when possible, and removing the stereo-
chemistry information.
7) Explicit hydrogen atoms were added, and 
structures were aromatized according to 
Hückel’s rules implemented in KNIME 
(Berthold et al. 2007).
8) The duplicates were removed using the 
IUPAC (International Union of Pure and 
Applied Chemistry) InChI (International 
Chemical Identifier) codes because these 
are unequivocal identifiers.
9) The final filter was applied to remove 
chemicals containing metals that often 
cause problems in molecular descriptor 
calculations.
Both training and prediction sets were 
processed by the same structure curation 
workflow. At the end of this procedure, 
32,464 unique structures—the 32 K set—
remained in the prediction set and 1,677 in 
the training set. These two data sets are made 
available for download in structure data file 
(SDF) format on the U.S. EPA ToxCast™ 
Data web site (https://www3.epa.gov/
research/COMPTOX/CERAPP_files.html, 
TrainingSet.zip and PredictionSet.zip) (U.S. 
EPA 2016). The identity of these chemicals 
(name, CASRN) was not provided to the 
participating modeling groups during the 
modeling process.
Modeling Approaches
The participant groups adopted different 
approaches and used several software programs 
(proprietary or open-source [commercial 
or free]) to calibrate categorical and contin-
uous models to the training data (Table 1). 
A categorical model is one that provides an 
active/inactive call for each chemical, whereas 
a continuous model provides a prediction of 
the potency (in μM) for each active chemical. 
Models were developed using both well-
known and innovative methods including 
partial least-squares (PLS) (Ståhle and Wold 
1987; Wold et al. 2001), partial least-squares 
discriminant analysis (PLS-DA) (Frank and 
Friedman 1993; Nouwen et al. 1997), decision 
forest (DF) (Hong et al. 2005, 2004; Tong 
et al. 2003; Xie et al. 2005), three-dimensional 
(3D) quantitative spectral data–activity 
relationship (QSDAR) (Beger et al. 2001; 
Beger and Wilkes 2001; Slavov et al. 2013), 
support vector machines (SVM) (Cristianini 
and Shawe-Taylor 2000), k nearest neighbors 
(kNN) (Cover and Hart 1967; Kowalski and 
Bender 1972), associative artificial neural 
networks (ASNN) (Tetko 2002a, 2002b), 
PASS algorithm derived from Naïve Bayes 
classifier (Poroikov et al. 2000), self-consistent 
regression with radial basis function interpo-
lation (RBF-SCR) (Zakharov et al. 2014), 
OCHEM machine learning methods (Tetko 
et al. 2014), docking and consensus of different 
approaches (Horvath et al. 2014; Ng et al. 
2014; Sushko et al. 2011). The set of 1,677 
chemicals provided by the U.S. EPA was used 
by more than 90% of the participating groups 
as a training set to fit their models (Judson 
Mansouri et al.
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et al. 2015), but some pre-existing models were 
also used that had been trained using other 
data sets from the literature such as METI 
(2002). In addition, each group performed its 
own analysis to select the appropriate chemi-
cals to be considered as a training set according 
to their particular modeling procedure. For 
descriptor calculation and docking procedures, 
some of the programs used were LeadScope 
(Roberts et al. 2000), PaDEL-Descriptor 
(Yap 2011), QikProp (version 3.4, http://
www.schrodinger.com/QikProp/), multilevel 
and quantitative neighborhoods of atoms 
(MNA, QNA) used by GUSAR and PASS 
(Filimonov et al. 2009; Poroikov et al. 2000), 
DRAGON (Talete srl 2012), Mold2 (Hong 
et al. 2008, 2012), GLIDE (version 6.5, http://
www.schrodinger.com/Glide), AutoDock 
(Goodsell et al. 1996), ISIDA (Varnek et al. 
2008), and other fingerprint generators. Some 
of the participants applied feature selection 
techniques, such as genetic algorithms (GAs) 
(Davi 1991) and random forest (RF) (Breiman 
2001). These techniques were applied after 
calculating descriptors to reduce collinearity 
and variable dimensionality to keep only the 
most informative descriptors in the models.
Evaluation Procedure for the 
Categorical and Continuous Models
All molecular structures of chemicals collected 
for the evaluation set from the different 
sources were curated and standardized using 
the previously described KNIME workflow 
(Table S2, step 2). All data used as the 
evaluation set for categorical and contin-
uous models are available on the U.S. EPA 
ToxCast™ web site (https://www3.epa.gov/
research/COMPTOX/CERAPP_files.html, 
EvaluationSet.zip) (U.S. EPA 2016).
Standard InChI codes were generated in 
KNIME and used to identify the chemicals. 
Data-mining tools available in the KNIME 
environment were used to concatenate and 
unify the different information fields from the 
different sources (CASRN, chemical name, 
original structure, standardized structure, 
InChI code, assay name, assay class, protein 
subtype, species, end point name, end point 
value, end point unit, and literature reference). 
Although ToxCast™ chemicals were used in 
the training sets of many models, they were 
not removed from the evaluation set to inves-
tigate how the predictions will perform on the 
literature data because there are differences 
between the AUC values and the literature 
data and because the sources from which the 
evaluation set was collected were not fully 
verified (we cannot assume that all cytotoxicity 
information was already fully cleaned).
Evaluation set for categorical models. An 
important issue with the literature-derived 
evaluation set was the inconsistency of the 
results from different sources. To minimize 
this, the available entries for each chemical 
structure were grouped into binders, agonists, 
and antagonists. The results were then cate-
gorized into active and inactive classes using 
all available literature sources by applying 
three rules:
1) If, for a specific chemical within one of 
the three classes (binding, agonist, and 
antagonist), the disagreement among the 
different sources exceeded 20% (e.g., two 
sources indicating active agonist and three 
indicating inactive agonist), that chemical 
was removed from the evaluation data set 
of that specific class.
2) If a chemical was an active agonist 
or antagonist, it also was considered as 
an active binder if the information was 
not available.
3) If a chemical was an inactive agonist and 
inactive antagonist, it was considered 
also as nonbinder if the information was 
not available.
This procedure resulted in a total of 
7,522 unique chemical structures with 
activity data to be used for evaluation of 
the categorical models (Table 2). It is also 
available for download on the U.S. EPA 
ToxCast™ web site (https://www3.epa.gov/
research/COMPTOX/CERAPP_files.html, 
EvaluationSet.zip) (U.S. EPA 2016).
Evaluation set for continuous models. For 
active chemicals with available quantitative 
information from concentration-response 
assays, the log10-median of the literature 
values was calculated. Only entries with 
equivalent end points were considered (e.g., 
PC50 and EC50). This resulted in 7,253 
unique chemicals with quantitative infor-
mation (Table 3 and https://www3.epa.
gov/research/COMPTOX/CERAPP_files.
html, EvaluationSet.zip) (U.S. EPA 2016). 
To reduce the variability that increased with 
the disparate literature sources, the chemicals 
with quantitative information were catego-
rized into five potency activity classes: inactive, 
very weak, weak, moderate, and strong. These 
five classes were used to evaluate the quanti-
tative predictions. A list of 36 known active 
and inactive reference chemicals was used for 
calibrating the mapping from quantitative 
potency values to the activity potency classes 
(Judson et al. 2015). These same chemicals 
were used to validate the mathematical model 
used to generate the AUC values for the 
training set. The following thresholds were 
applied to the concentration–response values:
Table 1. Methods adopted by the participant groups (alphabetic order) in the modeling procedure.
Model name Calibration method Descriptors software/type Training set (No. of chemicals) Predictions type
DTU PLS/fragments Leadscope METI (595,481)/ToxCast™ (1,422) Categorical
EPA_NCCT GA + PLSDA PADEL ToxCast™ (1,529) Categorical
FDA_NCTR_DBB (Ng et al. 2014) DF Mold2 ToxCast™ (1,677) Categorical
FDA_NCTR_DSB PLS 3D-SDAR ToxCast™ (1019) Categorical
ILS_EPA (Zang et al. 2013) SVM + RF Qikprop ToxCast™ (1,677) Categorical
IRCCS_CART (Roncaglioni et al. 2008) CART-VEGA 2D descriptors METI (806) Categorical
IRCCS_Ruleset Ruleset SMARTS ToxCast™ (1,529) Categorical
JRC_Ispra (Poroikov et al. 2000) PASS MNA — Categorical
Lockheed Martin kNN Fingerprints ToxCast™ (1,677) Categorical + continuous
NIH_NCATS Docking AutoDock score — Categorical
NIH_NCI_GUSAR (Filimonov et al. 2009) RBF-SCR MNA, QNA ToxCast™ (1,677) Categorical
NIH_NCI_PASS (Poroikov et al. 2000) PASS MNA ToxCast™ (1,677) Categorical
OCHEM (2015) Consensus 11 Descriptor types ToxCast™(1,660) Categorical + continuous
RIFM SVM Fingerprints ToxCast™ (1,677) Categorical
Umeå (Rybacka et al. 2015) ASNN DRAGON METI + (Kuiper et al. 1997; Taha et al. 2010) Categorical
UNC_MML SVM+RF DRAGON ToxCast™ (120) Categorical
UNIBA (Trisciuzzi et al. 2015) Docking GLIDE score ToxCast™ (1,677) Categorical
UNIMIB kNN DRAGON + fingerprints ToxCast™ (1,677) Categorical
UNISTRA (Horvath et al. 2014) SVM ISIDA ToxCast™ (1,529) Categorical + continuous
Predictions type: A categorical model is one that provides an active/inactive call for each chemical, whereas a continuous model provides a prediction of the potency (in μM) for 
each active chemical. Calibration methods: PLS (partial least-squares), PLS-DA (partial least-squares discriminant analysis), SVM (support vector machines), RF (random forest), DF 
(Decision forest), kNN (k nearest neighbors), ASNN (associative artificial neural networks), PASS (algorithm derived from Naïve Bayes classifier), RBF-SCR (self-consistent regression 
with radial basis function interpolation).
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• Strong: Activity concentration below 
0.09 μM.
• Moderate: Activity concentration between 
0.09 and 0.18 μM.
• Weak: Activity concentration between 0.18 
and 20 μM.
• Very Weak: Activity concentration between 
20 and 800 μM.
• Inactive: Activity concentration higher than 
800 μM.
The five classes were assigned scores from 
0 (inactive) to 1 (strong) with 0.25 incre-
ments. Then, for each chemical, the arithmetic 
mean of the scores of the merged entries from 
different literature sources was calculated. A 
new class was assigned to the merged entries 
according to the following thresholds.
• Strong: Average score > 0.75
• Moderate: 0.5 < Average score between 
≤ 0.75
• Weak: 0.25 < Average score ≤ 0.5
• Very weak: 0 < Average score ≤ 0.25
• Inactive: Average score = 0
The number of entries in each class 
for binding, agonist, and antagonist are 
 summarized in Table 3.
Evaluation procedure. This section is 
focused on the categorical models for their 
high number compared to the continuous 
models. The procedure used to evaluate the 
predictions of the participant groups was based 
on the categorical and continuous experi-
mental data from ToxCast™ and the evalua-
tion set from the literature. All continuous and 
categorical models for binding, agonist, and 
antagonist were evaluated separately on the 
overlap between their predicted chemicals and 
the following sets of chemicals (Table S3).
• Chemicals in the U.S. EPA’s ToxCast™ data 
set (n = 1,529 chemicals after excluding those 
in the ambiguous AUC range of 0.01–0.1).
• All chemicals in the full literature data (all 
literature sources combined).
• All chemicals with at least two litera-
ture sources.
• All chemicals from the literature data 
excluding the very weak actives.
• Chemicals within the applicability domain 
(AD) of each model (if provided).
• Chemicals remaining after applying the 
previous three filters in steps 3, 4, and 5 
to reduce ambiguous predictions (single 
literature source, very weak actives, and 
predictions outside the AD).
To evaluate the models on different 
criteria, we first determined the sensitivity 
(fraction of accurately predicted actives out of 
all actives), specificity (fraction of accurately 
predicted inactives out of all inactives), and 
balanced accuracy (BA; average of sensitivity 
and specificity) for each subgroup of chemi-
cals according to each model. We then used 
BA values to derive two summary scores for 
each model, as described below.
Score_1. Evaluation includes BA of each 
of the six steps weighted by the fraction of 
predicted chemicals of the same step, as well as 
the fraction of the predicted chemicals out of 
the full prediction set. This score (Equation 1) 
favors models with a wider AD and those 
predicting a maximum number of chemicals.
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where BA is balanced accuracy, N_pred is the 
number of predicted chemicals by a specific 
model, N_total is the total number of chemi-
cals in the prediction set, Nfilters represents the 
number of five filters applied to the evaluation 
set chemicals and i the steps 2, 3, 4, 5, and 6.
Score_2. Evaluation includes the BA of 
the model on the ToxCast™ data and the 
BA on the unambiguous chemicals (i.e., 
the subgroup of chemicals from the litera-
ture that remained after excluding chemicals 
with only one literature source, very weak 
chemicals, and chemicals outside of the AD, 
if provided). It favors models that focused 
on predicting more accurately but potentially 
with a narrower AD (Equation 2).
 score_2 = 1⁄2 (BAToxCast + BAall filters) [2]
The quantitative predictions were evalu-
ated as categorical models (using the BA) of 
the five classes after converting the numerical 
predictions to potency classes as defined 
earlier (see “Evaluation set for continuous 
models” section). Scores of the continuous 
models were calculated using Equation 2.
Consensus Modeling
The consensus predictions were gener-
ated for binders, agonists, and antagonists 
separately. For each chemical, we derived 
the average Score 2 value for all categorical 
models that predicted the chemical as active, 
and the average Score 2 value for all cate-
gorical models that predicted the chemical 
as inactive; we used the higher of the two 
averages to classify the chemical as active 
or inactive. Models that did not provide a 
prediction for the chemical in question were 
not included when deriving the average 
scores. We used Score 2 to derive the 
consensus classifications because its value 
for individual models is not penalized for 
the number of chemicals not predicted by 
the model. Also, the concordance among 
models on both active and inactive classes 
was calculated for each chemical as the 
fraction of models with positive and negative 
prediction, respectively.
Considering only the models that 
provided predictions, the sum of the concor-
dance among models for actives and inac-
tives is equal to 1. Because most models were 
associated with comparable scores, the average 
score used to classify chemicals was mostly 
in agreement with model concordance (i.e., 
the average score for actives is high when the 
concordance among the models with active 
predictions is high and vice versa). The few 
exceptions were noticed when model concor-
dance was around 0.5, which means only one 
or two models were driving the classification.
For continuous predictions, the weight 
(w) for each chemical i was calculated from 
the scores (Equation 3):
 w score score
1
i i j
j
n
=
=
/|  [3]
where n is the total number of models that 
provided predictions for the chemical i, and 
scorej is the score of the jth model predicting 
chemical i.
Next, the consensus potency level Ci of 
each chemical was determined using the 
predicted potency classes Pj of the n available 
models and their corresponding weights w as 
follows (Equation 4): 
 C w P
1
i j
j
n
j#=
=
|  [4]
Table  2. Evaluation set for binary categorical 
models. Distribution of the number of active and 
inactive chemicals within the three different 
classes: binding, agonists and antagonists.
Class/activity Active Inactive Total
Binding 1,982 5,301 7,283
Agonist 350 5,969 6,319
Antagonist 284 6,255 6,539
Total 2,017 7,024 7,522
The classification into actives and inactives is based on 
a consensus between the literature data sources that 
were in agreement.
Table 3. Evaluation set for quantitative models. Distribution of the number of chemicals in the five 
potency levels within the three different classes (binding, agonists, and antagonists), classifications 
based on average scores.
Class/activity Inactive Very weak Weak Moderate Strong Total
Binding 5,042 685 894 72 77 6,770
Agonist 5,892 19 179 31 42 6,163
Antagonist 6,221 76 188 10 10 6,505
Total 6,892 702 916 81 93 7,253
The classification of the chemicals in the five potency levels is based on the concentration responses from the literature 
sources that were in agreement.
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Results and Discussion
Models and Evaluation
A total of 48 models were received from the 
17 participant groups. Each group provided 
at least 1 categorical model for binding. 
Only 8 groups built models for agonists, and 
6 groups built models for antagonists. The 
limited number of models for agonists and 
antagonists was the result of the low number 
of actives, which caused the training set to 
be highly unbalanced. The total number 
of models in each class (Table 1; see also 
Tables S3 and S5) was a) binding models: 
21 categorical and 3 continuous, b) agonist 
models: 11 categorical and 3 continuous, 
and c) antagonist models: 8 categorical and 
2 continuous.
The participating groups provided predic-
tions for uneven fractions of the 32 k set. 
AD information on model predictions was 
provided by only six groups. All predictions 
for the individual models are provided on the 
U.S. EPA ToxCast™ web site (https://www3.
epa.gov/research/COMPTOX/CERAPP_
files.html, Models.zip) (U.S. EPA 2016).
The same evaluation procedure was 
applied to all models following the previously 
described steps. Note that some models were 
built using training sets other than what was 
provided in CERAPP and that these alter-
native training sets were not all publicly 
available. Hence, none of the training set 
chemicals were excluded from the evaluation 
sets (Table 1). Each model was evaluated on 
the overlap between the predicted chemi-
cals and the two previously mentioned data 
sets: ToxCast™ data and the evaluation set 
collected from the literature. The evaluation 
results for categorical models are summarized 
in Table S3. The detailed statistics, including 
sensitivity and specificity, are provided 
in Table S4.
Most compounds were predicted as 
 inactives and the models seemed to be more 
in agreement in predicting inactives than 
active compounds. Only 757 chemicals 
(2.33%) are predicted as actives by more 
than 75% of binding models. The agreement 
among the binding models for the 32 k set of 
the  prediction set is illustrated in Figure S1.
Most categorical models (binding, 
agonist, and antagonist) are associated with 
high balanced accuracies on the ToxCast™ 
data (> 0.8), with no clear difference between 
models that used it as a training set and those 
that did not (see Table S3). However, for 
the evaluation set from the literature, the 
BA is clearly lower for all models (< 0.7). 
Nonetheless, the BA increased after removing 
chemicals with only one source from the 
literature data. This result could mean that 
this first filter (i.e., removing chemicals with 
limited information in the literature for 
being either positive or negative) reduced the 
uncertainty in the experimental data from 
the literature. This is in agreement with 
related studies showing that the results of 
QSAR models may change depending on 
the robustness of the experimental values 
(Steinmetz et al. 2014). The second filter (i.e., 
removing very weak actives) also increased 
the BA, which suggests that the literature 
data may contain a number of false posi-
tives. Alternatively, the in vitro assays used 
by ToxCast™/Tox21 only test chemicals up 
to 100 μM, so very weak chemicals may not 
be picked up by these assays and some of the 
literature reports may have tested chemicals 
up to much higher concentrations.
Finally, removing predictions outside 
the AD did not show improvement of the 
BA of the categorical models (see Table S3). 
This is in agreement with literature sources 
showing that predictions outside the AD are 
not always less accurate than those within its 
limits (Sahigara et al. 2012). The performance 
of most models showed a clear improvement 
of 0.05 to 0.1 on the BA after applying all 
the filters on the literature data to keep only 
the unambiguous chemicals. We believe 
that this effectively reduced the uncertainty 
of the literature sources. This step also high-
lighted differences between ToxCast™ and the 
literature data and confirmed the existence of 
uncertainty in the literature data. Uncertainty 
and data discordance was also reported in 
literature review of in vivo uterotrophic 
 bioassays (Kleinstreuer et al. 2015).
The calculated scores for categorical 
models (see Table S3) take into consid-
eration the whole prediction set (Score_1) 
and the accuracy of the model on its most 
reliable predictions (Score_2). The models 
that provided predictions for the whole or 
most of the 32 k set of chemicals, and had 
wide ADs, showed high Score_1 values 
(Umeå 0.82, OCHEM 0.83). Whereas 
models with predictions for smaller fractions 
of the prediction set and narrow AD showed 
better Score_2 values (UNIMIB_2 0.85, 
UNIBA 0.80). NIH_NCI_GUSAR (0.87 
and 0.84) and FDA_NCTR_DBB (0.88 
and 0.84) showed the highest values for both 
Score_1 and Score_2. Part of the differences 
among model scores could result from the 
 uncertainty in the literature data.
The BAs of all antagonist models was low 
compared with binding and agonist models 
(see Table S3). This may be due to the highly 
unbalanced training set with a low number 
of active antagonist chemicals. Additionally, 
antagonism activity (in either ToxCast™ or 
the literature) can be confounded with cyto-
toxicity because antagonist transactivation 
assays are loss-of-signal assays.
The predictions of all continuous models 
were first converted to five classes using the 
list of reference chemicals as described in the 
evaluation set section (see “Evaluation set for 
continuous models” section). The predic-
tions were then evaluated on the ToxCast™ 
data and the literature data to calculate the 
average of BA of the different evaluation steps 
as the score of each model (see Table S5). All 
models showed high BA on ToxCast™ data 
and relatively good BA on the evaluation set.
Consensus Model
The consensus predictions were first evalu-
ated on the ToxCast™ data and then on the 
evaluation set from the literature. The total 
number of predicted active binders was 2,661 
out of the 32 k set of chemicals (8.2%) based 
on the method described in the “Materials 
and Methods” section “Consensus Modeling.”
Confusion matrices (Table 4) and predic-
tion statistics (Table 5) revealed a clear 
accuracy difference between the categorical 
consensus for binding on the ToxCast™ data 
and on the evaluation set. This difference 
could result from the fact that the ToxCast™ 
data, based on a model with inputs from 18 
different assays, were used by most of the 
models as a training set, which we presume 
reduces the uncertainty. This is in contrast 
to the literature data, where the number of 
sources per chemical varied from one to a few 
hundreds. When only the subset of the evalu-
ation set with more than six literature sources 
Table 4. Confusion matrices of categorical consensus predictions for binding.
Observed/predicted
ToxCast™ data 
predicted actives
ToxCast™ data 
predicted inactives
Literature evaluation set 
(all: 7,283) 
predicted actives
Literature evaluation set 
(all: 7,283) 
predicted inactives
Observed actives 76  13 467 1,515
Observed inactives 25 1,415 268 5,033
Table 5. Statistics of categorical consensus predictions for binding on ToxCast™ and literature data.
Statistics/used data ToxCast™ data
Literature evaluation set 
(all: 7,283)
Literature evaluation set 
(> 6 sources: 1,257)
Sensitivity 0.85 0.23 0.85
Specificity 0.98 0.95 0.97
Balanced accuracy 0.92 0.59 0.91
The literature data with more than six sources represents the most consistent part of the evaluation set.
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per chemical was considered, a large increase 
in the sensitivity was noticed (0.23 to 0.85).
To better understand the effect of 
the number of sources on the classification 
accuracy, ROC (receiver operating charac-
teristic) curves were made using the fraction 
of the binding models in each class as a 
threshold for the classification predictions and 
increasing the number of literature sources of 
the evaluation set. The ROC plot shows an 
improvement of the classification accuracy of 
the consensus model as the number of sources 
increases (Figure 1). Note that the same level 
of consistency (i.e., 80%) was required to 
merge the sources regardless of the number 
of sources (see rule 1 in the “Evaluation set 
for categorical models” section). This could 
lead to the conclusion that the low classifica-
tion accuracy on the full literature data is not 
because of a lack of accuracy of the consensus 
predictions, but rather to noise and experi-
mental uncertainty in the literature data. We 
assume that the high number of false negatives 
in the confusion matrix of Table 4 is caused 
by false positives in the full literature data for 
chemicals tested only a small number of times. 
Thus, by considering a higher number of 
sources (i.e., six), the number of false positives 
is reduced from the evaluation set and so the 
number of predicted false negatives decreased. 
This is in agreement with what was observed 
in the literature (Steinmetz et al. 2014).
Corrections to the Consensus 
Model
The first step of consensus modeling was 
conducted in an independent way for the 
categorical and continuous models on binding, 
agonist, and antagonist predictions. This led 
to a number of inconsistencies because some 
chemicals were predicted as active in categorical 
predictions but inactive in quantitative and 
vice versa. In addition, some chemicals were 
predicted as active agonists or antagonists but 
non-binders. To make all predictions more 
consistent, a number of corrections were 
applied on the first consensus predictions. 
Because the goal of this project was to help in 
a regulatory prioritization procedure, the modi-
fications aimed to reduce the number of false 
negatives but without adding an excess of false 
positives. The rules that were followed to obtain 
the final consensus predictions are as follows:
1) If a chemical i is active in the categorical 
consensus, then it is also considered active 
in the quantitative consensus.
2) If a chemical i is active in the quantita-
tive consensus and predicted as active 
by at least three categorical models, then 
it is also considered active in the cate-
gorical consensus.
3) If a chemical i is predicted active by less 
than three categorical models, then it is 
considered inactive also in  quantitative 
consensus.
These three rules were applied on the 
agonist and antagonist consensus models first, 
then on the binding consensus. A fourth rule 
was added to establish consistency between 
agonist and antagonist consensus models and 
the binding consensus model.
4) If a chemical i is an active agonist or 
active antagonist, then it is considered 
as active in categorical binding consensus, 
and its potency level in the quantitative 
binding consensus is made equal to its 
potency level as agonist/antagonist.
An analysis of variance in concordance 
in each potency level of the active chemicals 
in the continuous models (very weak, weak, 
moderate, and strong) is presented as a 
box-plot in Figure 2. Based on this figure, we 
noticed a correlation between the concordance 
of the categorical models and the potency level 
of active chemicals. This implies that models 
are more in agreement for strong actives 
and that the weaker a chemical is the more 
difficult it is to accurately predict. Therefore, 
the very weak chemicals are the main source 
of discordance among the different in silico 
models and also are the most uncertain 
experimentally. This relationship between 
positive concordance (agreement between 
models on predictions for active chemicals) 
and potency level for active chemicals can be 
used to set a quantitative prediction to the 
newly reclassified active chemicals using the 
previously mentioned rule 1 of the correc-
tions applied to the consensus predictions. The 
following thresholds were considered for each 
potency level:
• Strong: Concordance among models ≥ 0.9
• Moderate: 0.75 ≤ Concordance among 
models < 0.9
• Weak: 0.6 ≤ Concordance among models 
< 0.75
• Very weak: Concordance among models 
< 0.6
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Figure 1. ROC curves of the categorical corrected consensus predictions for binding evaluated against 
different sets of the evaluation set with variable numbers of literature sources. The number of available 
chemicals in the evaluation set (between brackets) decreased with higher numbers of literature sources. 
The true and false positive rates are determined based on the number of actives in the different sets of the 
evaluation set.
Figure 2. Box-plot of the positive class potency 
levels in the corrected quantitative consensus 
predictions for binding. The concordance between 
models is the fraction of the number of models that 
agrees on the prediction of a certain chemical. 
Boxes extend from the 25th to the 75th percentile, 
horizontal bars represent the median, whiskers 
indicate the 10th and 90th percentiles, and outliers 
are represented as points.
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After applying the four correction rules 
on consensus predictions, the total number 
of chemicals predicted as actives increased 
from 2,661 to 4,001, which corresponds to 
12.3% of the total number of the predic-
tion set (32,464). Table 6 shows the number 
of reclassified chemicals based on each one 
of the four correction rules applied to the 
consensus predictions. After this step, the 
predicted activity of several chemicals has 
changed. The structural information of 
chemicals and the predictions of the consensus 
model for the whole 32 k set are provided 
on the U.S. EPA ToxCast™ web site (see 
https://www3.epa.gov/research/COMPTOX/
CERAPP_files.html, PredictionSet.zip) 
(U.S. EPA 2016).
The confusion matrices and statistics 
for the binding categorical consensus model 
after modifications evaluated on ToxCast™ 
data and the literature data are presented 
in Table 7 and Table 8, respectively. The 
effect of the number of sources on the clas-
sification accuracy of the consensus model is 
illustrated by a bar plot in Figure S2. This 
figure shows an improvement of sensitivity 
with the increase in the number of literature 
sources in the evaluation set (from ~ 0.3 with 
at least one source to > 0.6 with six sources 
and more). This is translated into an increase 
in BA, whereas specificity is almost constant 
(~ 0.9) because of the high number of  
inactives compared to active compounds.
The results of this project and the 
ToxCast™ data used as the training set are 
published online in the EDSP21 dashboard, 
together with other structural and experi-
mental assay information (see “Consensus 
CERAPP QSAR ER Model Predictions” 
under “Chemical Summary” tab on http://
actor.epa.gov/edsp21) (U.S. EPA 2014c). 
A comparison of the single classification 
models to the consensus predictions for the 
whole 32 k set of chemicals is provided in 
Table S6. The calculations are done using 
the categorical consensus predictions as the 
“observed response.”
For regulatory or prioritization purposes, 
one could use a looser definition of active 
(i.e., allow more disagreement among models) 
in order to further reduce the chance of 
false negatives. Figure 3 shows the number 
of chemicals that can be predicted as poten-
tial actives by the categorical consensus for 
binding using various positive concordance 
(agreement on actives between the included 
models) thresholds. When this threshold is 
set to 0.2, an additional 6,742 more chemi-
cals can be added to the potential positives 
(this refers to the available binding models). 
This figure also shows the BA variations at 
different numbers of literature sources in the 
literature. Balanced accuracy increases as the 
concordance threshold increases from 0 to 0.2 
because sensitivity increases (false negatives 
decrease) as the number of chemicals classi-
fied as active increases. For chemicals with the 
highest data quality (seven or more sources), 
the BA curve reaches a plateau at concor-
dance thresholds of 0.4–0.5, and the number 
of chemicals classified as active is consistent 
with the number of active chemicals predicted 
from our consensus model (n = 4,001.) 
However, higher concordance thresholds 
result in declining BA due to increasing 
numbers of false positive  predictions (i.e., 
decreasing specificity).
Conclusion
The collaborative efforts of the CERAPP 
participants resulted in consensus predictions 
of the ability of chemicals to interact with 
ER. Up to 48 separately developed categorical 
and continuous models were received from 
17 research groups from the United States 
and Europe. Separate models were built for 
agonist, antagonist, and binding activity. The 
models were applied to a large collection of 
32,464 chemical structures that approximate 
the human exposure universe (chemicals 
with potential human exposure). A KNIME 
Table 6. Number of chemicals reclassified after applying each one of the four prediction correction rules.
Rule used for 
each class
Rule 1 Rule 2 Rule 3 Rule 4
Agonist Antagonist Binding Agonist Antagonist Binding Agonist Antagonist Binding Binding
Number of 
chemicals
1,288 2,760 1,587 217 14 344 145 161 38 966
Rule 1: Chemicals that changed from inactive to active in the quantitative consensus based on the categorical 
consensus. Rule 2: Chemicals that changed from inactive to active in the categorical consensus based on the quantita-
tive consensus. Rule 3: Chemicals that changed from active to inactive in the quantitative consensus based on the 
predictions of the categorical consensus. Rule 4: Chemicals that changed from inactive to active in the categorical 
binding consensus based on their agonist and antagonist activity in the categorical consensus.
Table 7. Confusion matrices of the modified categorical consensus predictions for binding.
Observed/predicted
ToxCast™ data 
predicted actives
ToxCast™ data 
predicted inactives
Literature evaluation set  
(All: 7,283)  
predicted actives
Literature evaluation set 
(All: 7,283)  
predicted inactives
Observed actives 83  6 597 1,385
Observed inactives 40 1,400 463 4,838
Table 8. Statistics of the modified categorical consensus for binding predictions on ToxCast™ and 
literature data.
Statistics/used data
ToxCast™ 
data
Literature evaluation set 
(All: 7,283)
Literature evaluation set 
(> 6 Sources: 1,275)
Sensitivity 0.93 0.30 0.87
Specificity 0.97 0.91 0.94
Balanced accuracy 0.95 0.61 0.91
Figure 3. Variation of the balanced accuracy of the corrected categorical consensus predictions for 
binding with positive concordance (agreement between models on predictions for active chemicals) 
threshold at different numbers of literature sources.
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workflow was developed to carefully curate 
the large collection of chemical structures to 
ensure consistency in model development 
and evaluation. Most of the models were 
trained using activities derived from a data set 
combining 18 in vitro assays from ToxCast™ 
probing various points of the ER pathway. 
Models were then evaluated using the 
ToxCast™ data plus a collection of ER in vitro 
data from the literature. After this process, 
categorical predictions were combined into a 
consensus to classify the chemicals into actives 
and inactives, while continuous predictions 
were combined to classify the actives into 4 
different potency classes: very weak, weak, 
moderate, and strong.
One major observation was that most 
models had comparable performances, inde-
pendent of the methods used, with a slight 
improvement for models with narrow ADs. A 
second and, perhaps, more important observa-
tion is that the most concordant predictions 
come from comparing the consensus of many 
models with a consensus of many literature 
sources. For instance, when comparing the 
consensus of the categorical binding models 
with the evaluation set from the literature 
for chemicals with seven or more sources, 
we achieve a balanced accuracy of about 
90% (Table 8).
We propose several important conclu-
sions from our results. First, there does not 
appear to be an optimal modeling approach 
(combination of descriptor set, feature selec-
tion, or machine learning algorithm) that 
will solve the QSAR/docking problem and 
achieve perfect prediction accuracies. Second, 
there are inherent limitations to the accuracy 
of the data being used to train QSAR and 
docking models. Our analysis of the literature 
data showed a disagreement in the reported 
activity of many chemicals. The sources of 
discrepancy include limits to the concentra-
tion ranges tested, true differential activity 
among tissue sources [e.g., the presence of 
selective ER modulators, SERMs (selective 
estrogen receptor modulators)], and a variety 
of experimental artifacts and errors. Figure 2 
shows that the most consistent predictions 
are achieved for the most potent compounds, 
whereas weaker compounds are called 
inactive by some laboratories because these 
compounds were not tested at a high enough 
concentration. So chemicals with very weak 
activity would be more likely to be incorrectly 
classified as inactive than more potent chemi-
cals. Therefore, 100% accuracy cannot be 
achieved due to these limitations in the exper-
imental data used for training and evaluation. 
Figures 1 and 3 help to illustrate this point by 
showing that higher consistency in the experi-
mental data is associated with an increase in 
the concordance among model predictions. 
But this comes at the cost of excluding parts 
of the experimental data. So, just as every 
model has limitations, every in vitro assay also 
has inherent variability in its results.
The major purpose of this study was 
to identify potential ER actives out of the 
large universe of chemicals to which humans 
potentially are exposed using a consensus of 
in silico models to overcome the limitations 
of single models. Most of the chemicals in 
this collection were predicted to be negatives, 
with a high agreement among the individual 
models. The disagreement was the highest 
for chemicals with weak activity (Figure 2). 
This disagreement is driven by the difficul-
ties in experimentally assessing the activity of 
these weak chemicals. In total, the consensus 
predicted 4,001 chemicals as actives. The 
testing of these active chemicals will be 
prioritized from the most potent to the least 
according to the continuous model consensus 
predictions. There are 6,742 more chemi-
cals that 20–50% of the models predicted 
to be positive, which could also be candi-
dates for follow-up analyses. Although this 
large number of chemicals (~ 10,000 in 
total) appears to be a daunting set to evaluate 
experimentally, this is equivalent in size to the 
current Tox21 library already being tested for 
activity in ER and many other targets.
In summary, this project demonstrates the 
feasibility of screening a large and toxicologi-
cally relevant library of chemical structures 
in an extensive battery of QSAR and docking 
models to meet important goals in human 
and environmental health. ER provides a 
good initial case because of the ready avail-
ability of experimental data and pre-existing 
models. However, through the ToxCast™ and 
Tox21 programs, and through other large 
scale data-integration projects, equivalently 
large data sets will become available for other 
multiple targets of environmental importance.
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